RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

TWINBEECH CAPITAL LP's Holding History (CIK: 0001769646)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 38,352 Value ($000) $157 Avg Close $4.95 Range $3.81 - $7.18

Q3 2024

Shares 535,079 Value ($000) $3,526 Avg Close $7.17 Range $5.88 - $8.73

Q2 2024

Shares 371,247 Value ($000) $2,784 Avg Close $8.72 Range $6.75 - $10.66

Q1 2024

Shares 313,487 Value ($000) $3,125 Avg Close $11.14 Range $8.68 - $15.74

Q1 2022

Shares 174,923 Value ($000) $1,252 Avg Close $10.63 Range $5.80 - $18.23

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	38,352	$157	$4.95	$3.81 - $7.18
Q3 2024	535,079	$3,526	$7.17	$5.88 - $8.73
Q2 2024	371,247	$2,784	$8.72	$6.75 - $10.66
Q1 2024	313,487	$3,125	$11.14	$8.68 - $15.74
Q1 2022	174,923	$1,252	$10.63	$5.80 - $18.23